MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemiaAthalia R. Pyzer, David Avigan, Hasan Rajabi et al.|Blood|2017Cited by 193
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissionsJacalyn Rosenblatt, David Avigan, Richard M. Stone et al.|Science Translational Medicine|2016Cited by 165
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host diseaseMyrna Nahas, Jacalyn Rosenblatt, Robert J. Soiffer et al.|Blood|2018Cited by 48
Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance‐conferring FLT3/tyrosine kinase domain/F691 mutationAmir T. Fathi, Mark J. Levis, Traci M. Blonquist et al.|Cancer|2017Cited by 31
Possible reactivation of chromosomally integrated human herpesvirus 6 after treatment with histone deacetylase inhibitorIoannis Politikos, Vassiliki A. Boussiotis, Malgorzata McMasters et al.|Blood Advances|2018Cited by 18